Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #51 to #300.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Dose coefficient‏‎ (5 revisions)
  2. Sievert‏‎ (4 revisions)
  3. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  4. High linear energy transfer radiation‏‎ (4 revisions)
  5. S coefficient (radiation weighted)‏‎ (4 revisions)
  6. Non-maleficence‏‎ (4 revisions)
  7. Bioassay‏‎ (4 revisions)
  8. Calculating Radon Doses‏‎ (4 revisions)
  9. Computed tomography dose index‏‎ (4 revisions)
  10. Direct bioassay‏‎ (4 revisions - redirect page)
  11. Mass median diameter‏‎ (4 revisions)
  12. Alpha decay‏‎ (4 revisions)
  13. Programmed cell death‏‎ (4 revisions)
  14. Effective charge number‏‎ (4 revisions)
  15. Math‏‎ (4 revisions)
  16. Averted dose‏‎ (4 revisions)
  17. Effective half-life‏‎ (4 revisions)
  18. Protective action‏‎ (4 revisions)
  19. Reference Animal and Plant‏‎ (4 revisions)
  20. Kp index‏‎ (4 revisions)
  21. ICRP‏‎ (4 revisions)
  22. Source-related assessment‏‎ (4 revisions)
  23. Forbiddenness‏‎ (4 revisions)
  24. Aerodynamic diameter‏‎ (4 revisions)
  25. Reference bioassay function‏‎ (4 revisions)
  26. Diagnostic reference level‏‎ (4 revisions)
  27. Risk‏‎ (4 revisions)
  28. Senescence‏‎ (4 revisions)
  29. Air-kerma, product‏‎ (4 revisions)
  30. Fractionation sensitivity‏‎ (4 revisions)
  31. Optimisation‏‎ (4 revisions)
  32. Personal dose equivalent‏‎ (3 revisions)
  33. Principle of justification‏‎ (3 revisions)
  34. Radiofrequency ablation‏‎ (3 revisions)
  35. Emergency preparedness‏‎ (3 revisions)
  36. Valvular heart disease‏‎ (3 revisions)
  37. Gray‏‎ (3 revisions)
  38. Auger transition‏‎ (3 revisions)
  39. Bystander effect‏‎ (3 revisions)
  40. Iso-effect plots‏‎ (3 revisions)
  41. Emergency procedures‏‎ (3 revisions)
  42. Lifetime risk estimates‏‎ (3 revisions)
  43. Absolute risk‏‎ (3 revisions)
  44. Virtue ethics‏‎ (3 revisions)
  45. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  46. Complex tissues‏‎ (3 revisions)
  47. Derived air concentration‏‎ (3 revisions)
  48. Dignity‏‎ (3 revisions)
  49. Isomers‏‎ (3 revisions)
  50. Employer‏‎ (3 revisions)
  51. Activity median thermodynamic diameter‏‎ (3 revisions)
  52. Voxel phantom‏‎ (3 revisions)
  53. Growth fraction‏‎ (3 revisions)
  54. Organ dose equivalent‏‎ (3 revisions)
  55. ICRP Publication 103‏‎ (3 revisions)
  56. Excretion rate (instantaneous)‏‎ (3 revisions)
  57. Extrathoracic airways‏‎ (3 revisions)
  58. Galactic cosmic radiation‏‎ (3 revisions)
  59. Growth hormone (somatotropin)‏‎ (3 revisions)
  60. Recovery‏‎ (3 revisions)
  61. DNA damage signalling‏‎ (3 revisions)
  62. Spread-out Bragg peak‏‎ (3 revisions)
  63. Fairness‏‎ (3 revisions)
  64. Absorption‏‎ (3 revisions)
  65. Gamma ray‏‎ (3 revisions)
  66. Biomedical research volunteer‏‎ (3 revisions)
  67. Cardiomyopathy‏‎ (3 revisions)
  68. Dose equivalent‏‎ (3 revisions)
  69. Field-size effect (Volume effect)‏‎ (3 revisions)
  70. Gastrointestinal syndrome‏‎ (3 revisions)
  71. Wisdom‏‎ (3 revisions)
  72. Autonomy‏‎ (3 revisions)
  73. Dose limit‏‎ (3 revisions)
  74. Target region‏‎ (3 revisions)
  75. Flexible tissues‏‎ (3 revisions)
  76. Guide to the System of Radiological Protection‏‎ (3 revisions)
  77. Constancy test‏‎ (3 revisions)
  78. Dose‏‎ (3 revisions)
  79. Dose limits‏‎ (3 revisions)
  80. Fluence‏‎ (3 revisions)
  81. Potential exposure‏‎ (3 revisions)
  82. DS02‏‎ (3 revisions)
  83. Fluoroscopically guided interventions‏‎ (3 revisions)
  84. Annual dose‏‎ (3 revisions)
  85. Cell death‏‎ (3 revisions)
  86. Contamination‏‎ (3 revisions)
  87. Rigidity threshold‏‎ (3 revisions)
  88. Dose of record (E)‏‎ (3 revisions)
  89. Low Earth orbit‏‎ (3 revisions)
  90. Accountability‏‎ (3 revisions)
  91. X ray‏‎ (3 revisions)
  92. Half-life, physical‏‎ (3 revisions)
  93. Annual limit on intake‏‎ (3 revisions)
  94. Exponential survival curve‏‎ (3 revisions)
  95. Unsealed source‏‎ (3 revisions)
  96. Xerostomia‏‎ (3 revisions)
  97. Public exposure‏‎ (3 revisions)
  98. Dose per content function‏‎ (3 revisions)
  99. Interphase death‏‎ (3 revisions)
  100. Equity‏‎ (3 revisions)
  101. Test‏‎ (3 revisions)
  102. Graded approach‏‎ (3 revisions)
  103. Fractionation‏‎ (3 revisions)
  104. Uptake‏‎ (3 revisions)
  105. Active (red) bone marrow‏‎ (3 revisions)
  106. Utilitarian ethics‏‎ (3 revisions)
  107. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  108. Operational quantity‏‎ (3 revisions)
  109. Coster-Kronig transition‏‎ (3 revisions)
  110. Value judgement‏‎ (3 revisions)
  111. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  112. High level waste‏‎ (2 revisions)
  113. Clearance‏‎ (2 revisions)
  114. Deontological Ethics‏‎ (2 revisions)
  115. Repopulation‏‎ (2 revisions)
  116. Differentiation‏‎ (2 revisions)
  117. Routine monitoring‏‎ (2 revisions)
  118. ICRPædia Guide to Radon‏‎ (2 revisions)
  119. Special (non-routine) monitoring‏‎ (2 revisions)
  120. Lifetime risk‏‎ (2 revisions)
  121. Macrophage colony stimulating factor‏‎ (2 revisions)
  122. Multiplicative risk projection model‏‎ (2 revisions)
  123. Activity‏‎ (2 revisions)
  124. Beta-minus decay‏‎ (2 revisions)
  125. Clearance level‏‎ (2 revisions)
  126. Radiographer‏‎ (2 revisions)
  127. Representative organism (non-human biota)‏‎ (2 revisions)
  128. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  129. Dose constraint‏‎ (2 revisions)
  130. Early normal tissue responses‏‎ (2 revisions)
  131. Threshold dose for tissue reactions‏‎ (2 revisions)
  132. Magnetosphere‏‎ (2 revisions)
  133. Pharynx‏‎ (2 revisions)
  134. Beta-plus decay‏‎ (2 revisions)
  135. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  136. Cumulative dose‏‎ (2 revisions)
  137. Representative person‏‎ (2 revisions)
  138. Safety‏‎ (2 revisions)
  139. Dose conversion coefficient‏‎ (2 revisions)
  140. Edema‏‎ (2 revisions)
  141. Specific effective energy‏‎ (2 revisions)
  142. Limitation of dose‏‎ (2 revisions)
  143. Excess relative risk‏‎ (2 revisions)
  144. Exposure situation‏‎ (2 revisions)
  145. Transmission detection system‏‎ (2 revisions)
  146. Multistage tumorigenesis‏‎ (2 revisions)
  147. Non-sphericity parameter‏‎ (2 revisions)
  148. Growth factor‏‎ (2 revisions)
  149. Alimentary tract transfer factor‏‎ (2 revisions)
  150. Hormones‏‎ (2 revisions)
  151. Authorization‏‎ (2 revisions)
  152. Procedural values‏‎ (2 revisions)
  153. Clonogenic cells‏‎ (2 revisions)
  154. Curie‏‎ (2 revisions)
  155. Reproductive integrity‏‎ (2 revisions)
  156. Safety case‏‎ (2 revisions)
  157. Slow repair‏‎ (2 revisions)
  158. Effect Dose 50‏‎ (2 revisions)
  159. Isotropic geometry‏‎ (2 revisions)
  160. Endogeneous excretion‏‎ (2 revisions)
  161. Lineal energy‏‎ (2 revisions)
  162. Thyroid blocking‏‎ (2 revisions)
  163. Exposure to Radon at Home‏‎ (2 revisions)
  164. Transparency‏‎ (2 revisions)
  165. GATA binding protein 2‏‎ (2 revisions)
  166. Waste disposal‏‎ (2 revisions)
  167. Non-targeted effects‏‎ (2 revisions)
  168. Hounsfield unit‏‎ (2 revisions)
  169. Authorized limit‏‎ (2 revisions)
  170. Planned exposure situation‏‎ (2 revisions)
  171. Progenitor cell‏‎ (2 revisions)
  172. Cardiac arrhythmias‏‎ (2 revisions)
  173. Radiation belt‏‎ (2 revisions - redirect page)
  174. Clonogenic survival‏‎ (2 revisions)
  175. Reasonableness‏‎ (2 revisions)
  176. Cytokines‏‎ (2 revisions)
  177. Residual dose‏‎ (2 revisions)
  178. Safety culture‏‎ (2 revisions)
  179. Solar cosmic radiation‏‎ (2 revisions)
  180. Inhalability‏‎ (2 revisions)
  181. Spontaneous fission‏‎ (2 revisions)
  182. Itinerant (radiation) worker‏‎ (2 revisions)
  183. Linear-non-threshold model‏‎ (2 revisions)
  184. Trapped particles‏‎ (2 revisions)
  185. Acute radiation syndrome‏‎ (2 revisions)
  186. Orphan source‏‎ (2 revisions)
  187. Autoimmune disease‏‎ (2 revisions)
  188. Platelet-derived growth factor‏‎ (2 revisions)
  189. ICRP Publication 118‏‎ (2 revisions)
  190. Cardiac valve diseases‏‎ (2 revisions)
  191. Radiation modifier‏‎ (2 revisions)
  192. Radiological protection principles‏‎ (2 revisions)
  193. Respiratory protection‏‎ (2 revisions)
  194. Disposal‏‎ (2 revisions)
  195. Scintigraphy‏‎ (2 revisions)
  196. Dose criteria‏‎ (2 revisions)
  197. Solar cycle‏‎ (2 revisions)
  198. Inner bremsstrahlung‏‎ (2 revisions)
  199. Environmental exposure‏‎ (2 revisions)
  200. Systemic model‏‎ (2 revisions)
  201. Linear-quadratic dose response model‏‎ (2 revisions)
  202. Exempt waste‏‎ (2 revisions)
  203. Time factor‏‎ (2 revisions)
  204. Myocardial perfusion‏‎ (2 revisions)
  205. Adaptive response‏‎ (2 revisions)
  206. What is Radon?‏‎ (2 revisions)
  207. Alveolar-interstitial region‏‎ (2 revisions)
  208. Projected dose‏‎ (2 revisions)
  209. Co-expertise‏‎ (2 revisions)
  210. Radionuclides of natural origin‏‎ (2 revisions)
  211. Connective tissue‏‎ (2 revisions)
  212. Recovery (cellular or tissue)‏‎ (2 revisions)
  213. DRL process‏‎ (2 revisions)
  214. Retrievability‏‎ (2 revisions)
  215. Immune system‏‎ (2 revisions)
  216. Institutional control‏‎ (2 revisions)
  217. Stakeholder‏‎ (2 revisions)
  218. Environmental radiation protection‏‎ (2 revisions)
  219. Tachycardia‏‎ (2 revisions)
  220. Exemption level‏‎ (2 revisions)
  221. Tissue equivalent material‏‎ (2 revisions)
  222. Myocardial stress test‏‎ (2 revisions)
  223. Oversight‏‎ (2 revisions)
  224. Hyperbaric oxygen‏‎ (2 revisions)
  225. Bioturbation‏‎ (2 revisions)
  226. Cardioverter-defibrillator‏‎ (2 revisions)
  227. Radiation safety officer‏‎ (2 revisions)
  228. Radioresponsiveness‏‎ (2 revisions)
  229. Consequential late effects‏‎ (2 revisions)
  230. Recovery responder‏‎ (2 revisions)
  231. Reversibility‏‎ (2 revisions)
  232. In vivo radiobioassay‏‎ (2 revisions)
  233. Solar particle event‏‎ (2 revisions)
  234. Effective dose equivalent‏‎ (2 revisions)
  235. Existing exposure situation‏‎ (2 revisions)
  236. Gastroschisis‏‎ (2 revisions)
  237. Worker‏‎ (2 revisions)
  238. Nuclear track detectors‏‎ (2 revisions)
  239. Angiogenesis‏‎ (2 revisions)
  240. Particle radiance‏‎ (2 revisions)
  241. Hyperfractionation‏‎ (2 revisions)
  242. Bone marrow‏‎ (2 revisions)
  243. Protection strategy‏‎ (2 revisions)
  244. Radiation source‏‎ (2 revisions)
  245. Cohort study‏‎ (2 revisions)
  246. Radiosensitiser‏‎ (2 revisions)
  247. DRL value‏‎ (2 revisions)
  248. Rehabilitation of living conditions‏‎ (2 revisions)
  249. Right to know‏‎ (2 revisions)
  250. Incidence‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)